Farther Finance Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Farther Finance Advisors’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-96	Closed	-$150	–	3963
2024 Q1	$150	Buy	+96	New	+$142	﹤0.01%	3318

Farther Finance Advisors's NGM Position: Q2 2024 in Review

Farther Finance Advisors sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 96 shares — an estimated $150 sold.

Farther Finance Advisors first reported a position in NGM in Q1 2024 and held it in 1 quarter. The position peaked at $150 in Q1 2024. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Farther Finance Advisors reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Farther Finance Advisors sold 96 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $150.
Farther Finance Advisors first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Farther Finance Advisors's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $150 in Q1 2024.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Farther Finance Advisors's 13F filing for Q2 2024, filed 31 Jul 2024.